MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Kindred Biosciences Company Profile (NYSE:KIN)

Consensus Ratings for Kindred Biosciences (NYSE:KIN) (?)
Ratings Breakdown: 2 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $5.00 (48.79% upside)

Analysts' Ratings History for Kindred Biosciences (NYSE:KIN)
Show:
DateFirmActionRatingPrice TargetActions
11/17/2015BMO Capital MarketsDowngradeOutperform -> Market Perform$14.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/13/2015Roth CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014Craig HallumDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014Leerink SwannDowngradeOutperform -> Market Perform$11.25 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/6/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha